semaglutide and colon cancer patients using GLP-1s had lower death rates: Study Wegovy and Ozempic tied to

Patejunas G, Lee B, Dennis JA, Healy PJ, Reeds PJ, Yu H, Frazer M, Mull B, Warman AW, Beaudet AL, OBrien WE (1998) Evaluation of gene therapy for citrullinaemia using murine and bovine models

A patient in Class I has no limitation in physical activity and may not require additional clearance, whereas a patient in Class III has symptoms with minimal exertion and may require a higher level of care, such as performing the procedure in a hospital setting for safety

GHK-Cu focuses on structural skin improvements like collagen production and wound healing, while NAD+ targets cellular energy and DNA repair

Retatrutide is the major investigational triple agonist targeting GIP, GLP-1, and glucagon receptors